Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Virology,Cellular and Molecular Neuroscience,Neurology (clinical),Neurology
Link
https://link.springer.com/content/pdf/10.1007/s13365-021-01028-1.pdf
Reference35 articles.
1. Alleg M, Solis M, Baloglu S et al (2020) Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML. Eur Radiol 1–12. https://doi.org/10.1007/s00330-020-07362-y. [published online ahead of print, 2020 Nov 6]
2. Antinori A, Ammassari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A (2001) Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J Neurovirol 7(4):323–328. https://doi.org/10.1080/13550280152537184
3. Boddy C, Bennett C, Norris L, Georgantopoulos P, Luo S, Carson K (2014) Rituximab-associated progressive multifocal leukoencephalopathy (PML) in HIV-negative patients: an updated report of 231 confirmed cases from the southern network on adverse reactions (SONAR)/Washington University Collaboration (2000–2012). Blood 124(21):4456–4456. https://doi.org/10.1182/blood.V124.21.4456.4456
4. Bohra C, Sokol L, Dalia S (2017) Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review. Cancer Control 24(4):1073274817729901. https://doi.org/10.1177/1073274817729901
5. Berger JR, Malik V, Lacey S, Brunetta P, Lehane PB (2018) Progressive multifocal leukoencephalopathy in rituximab treated rheumatic diseases: a rare event. J Neurovirol 24(3):323–331. https://doi.org/10.1007/s13365-018-0615-7. [published correction appears in J Neurovirol. 2018 Apr 10]
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis;Multiple Sclerosis Journal;2024-02-22
2. Combined treatment with allogeneic Epstein–Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report;Therapeutic Advances in Neurological Disorders;2024-01
3. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China;Journal of NeuroVirology;2023-10-28
4. Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management;Expert Review of Clinical Pharmacology;2023-05-04
5. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV;Current HIV/AIDS Reports;2022-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3